MITA Commends Proposed Medicare Coverage Decision for Low-Dose CT Scans to Detect Lung Cancer


Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) issued the following statement today in response to the Centers for Medicare & Medicaid Services’ (CMS) draft decision to cover annual low-dose computed tomography (LDCT) scans for Medicare beneficiaries who are at high risk for lung cancer:

“We commend CMS for its proposal to provide high-risk Medicare beneficiaries access to potentially life-saving scans,” said Gail Rodriguez, executive director of MITA. “Research shows that LDCT scans for individuals at high-risk of lung cancer could save up to 20,000 lives per year. Given lung cancer is the leading cause of cancer deaths, implementation of annual LDCT scans will improve outcomes through early detection and drive down treatment costs.  We encourage CMS to finalize this proposal so that Medicare beneficiaries can reap the benefits of this invaluable technology.”


The Medical Imaging & Technology Alliance (MITA), a division of NEMA, is the collective voice of medical imaging equipment, radiation therapy and radiopharmaceutical manufacturers, innovators and product developers. It represents companies whose sales comprise more than 90 percent of the global market for medical imaging and radiation therapy technologies. For more information, visit Follow MITA on Twitter @MITAToday.